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The design, synthesis and structural characterization of non-natural oligomers that adopt well-deﬁned
conformations, so called foldamers, is a key objective in developing biomimetic 3D functional architec-
tures. For the aromatic oligoamide foldamer family, use of interactions between side-chains to control
conformation is underexplored. The current manuscript addresses this objective through the design, syn-
thesis and conformational analyses of model dimers derived from 3-O-alkylated para-aminobenzoic acid
monomers. The O-alkyl groups on these foldamers are capable of adopting syn- or anti-conformers
through rotation around the Ar–CO/NH axes. In the syn-conformation this allows the foldamer to act as a
topographical mimic of the α-helix whereby the O-alkyl groups mimic the spatial orientation of the i and
i + 4 side-chains from the α-helix. Using molecular modelling and 2D NMR analyses, this work illustrates
that covalent links and hydrogen-bonding interactions between side-chains can bias the conformation in
favour of the α-helix mimicking syn-conformer, oﬀering insight that may be more widely applied to
control secondary structure in foldamers.
Introduction
The design and synthesis of foldamers that adopt well-defined
conformations represents the foundation for construction of
non-natural folded structures with well-defined secondary, ter-
tiary and quaternary structures1–6 possessing biomimetic and
emergent functions.7–11 The aromatic oligoamide foldamer
family12–25 has received considerable attention due to their
predictable and well-defined folding behaviour. Control over
conformation in the aromatic oligoamide family may be
achieved by harnessing judiciously positioned hydrogen-
bonding functionality along a planar backbone with well-
defined steric constraints.12–14 Elegant studies have estab-
lished the role of interactions between peripheral side chains
in regulating the conformation of β-peptides,26–28 however
such interactions in the aromatic oligoamide family and other
abiotic oligomers are less explored.29,30 This is surprising
given the role of interactions between adjacent side-chains in
controlling natural peptide conformation31–34 and in control-
ling conformation in self-assembled conjugated materials.35
Our group previously reported a series of aromatic oligoamide
scaﬀolds designed to mimic the α-helix and inhibit α-helix
mediated protein–protein interactions.36–39 For the 2- and 3-O-
alkylated scaﬀolds, these oligomers adopt an extended confor-
mation determined by the trans configuration of the amide
bond and in which rotation around the Ar–CO/NH axes is
restricted by S(6) or S(5) intramolecular hydrogen bonding
respectively (Fig. 1a for an illustration of the 3-O-alkylated
scaﬀolds).41,42 Given the free rotation around the remaining
amide–aryl bond in these oligomers, we observed no prefer-
ence for syn- or anti-conformers in helix mimetics derivatized
with simple alkyl alkoxy groups.41,42 Helix mimicry (Fig. 1b) of
an i and i + 4 cluster of side-chains (and the i + 7 position for
trimeric oligoamides) occurs where the oligomers adopt the
syn-conformation. Herein we demonstrate that covalent links
or hydrogen-bonding interactions between suitably functiona-
lized side-chains bias the conformation in favour of the syn-
conformer so as to further stabilize the helix mimicking
conformer in a manner that mirrors stabilisation of helical
conformation through i to i + 4 salt bridges (Fig. 1c).31,32,43
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Results and discussion
Using established solid-supported synthesis methodologies
developed by our group,44,45 model foldamer dimers 1–3 were
prepared (Fig. 1a, see ESI† for syntheses of novel monomers
and solid-phase assembly procedure), together with trimer 4.
Dimer 1 was synthesized bearing acid and amine terminated
side-chains with the hypothesis that these would promote a
syn-conformer through hydrogen-bonding; evidence that such
interactions between adjacent side-chains might control con-
formation in helix mimetics was obtained from studies in
which a constraint or “staple”30,46,47 between adjacent mono-
mers was introduced by olefin metathesis (discussed below for
trimer 4). Dimer 2 was synthesized bearing two acid side-
chains as a control predicted to disfavour the syn-conformation
due to repulsion of the carboxylic acids whilst dimer 3 was syn-
thesised bearing two aliphatic side-chains and predicted to
adopt a mixture of syn- and anti-conformers.
To provide evidence supporting the potential to exploit
interactions between peripheral side-chains for control of fol-
damer conformation, we first characterized trimer 4 by X-ray
and 2D NMR (Fig. 2). The molecules pack in the crystal lattice
with C–H⋯π interactions between the alkyl side chain and the
Fig. 1 Controlling conformation through side-chain side-chain inter-
actions in 3-O-alkylated aromatic oligoamides: (a) model dimers 1–3
used in this study illustrating syn-/anti-conformers; (b) model of dimer 1
superimposed on an α-helix illustrating ideal matching between the
O-alkyl groups and the α-carbons in the i and i + 4 positions (green
spheres); (c) segment of an α-helix bearing a stabilising salt bridge
between a Glu and Lys residue at the i and i + 4 positions in the helix
(excised from Crystal Structure of the Mosquito-Larvicidal Toxin Cry4Ba
PDB ID: 1 W99).40
Fig. 2 Analyses of covalently constrained trimeric aromatic oligoamide
foldamer 4 (a) single crystal structure analyses highlights the restricted
nature of rotation around the Ar2–CO axis enforced by the covalent link
and the anti-relationship of the groups either side of the Ar2–CO axis (b)
1H–1H NOESY spectrum of compound 4 demonstrating propensity for a
covalent link to restrict rotation in helix mimetics: (7–9 ppm, 500 MHz,
CDCl3, 40 mM).
Fig. 3 Molecular modelling structures illustrating potential confor-
mational landscape of helix mimetics: (a) dominant syn-conformer of 1
highlighting side-chain carboxylate and side-chain ammonium comple-
mentarity; (b) dominant anti-conformer of 2; (c) mixture of syn- and
anti-conformers observed for 3.
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benzyl group (not shown). This extended conformation is
stabilized through five membered N–H⋯O intramolecular
H-bonds (dNH1⋯O = 2.15 Å, dNH1⋯O: 2.17 Å, Fig. 2a). There
is clear evidence that rotation around the Ar2–CO axis by the
hydrocarbon “staple” axis is restricted; the alkoxy groups are
constrained to have a syn relationship, whereas unrestricted
rotation around the Ar1–CO axes is evidenced by the anti-
relationship between the benzyloxy and central alkoxy groups.
The 2D NMR data (Fig. 2b) further reinforce these conclusions
– whilst a 2NH to 2-H2 NOE is observed, a correlation between
2-NH and 2-H6 is absent indicative of the syn-conformation. In
contrast correlations are observed from 1-NH to 1-C2H and
1-NH to 1-C6H indicating free rotation around the Ar1–CO axis
and a mixture of syn- and anti-conformers.
To characterize the conformational preferences of these
dimers, molecular modelling was performed. A Monte Carlo
Multiple Minima (MCMM) molecular mechanics conformational
search was carried out using MacroModel (Schrödinger) and the
Merck Molecular Force Field (MMFF) force field in implicit
water and with fixed ionisation state on the aromatic oligoamide
side-chains (Fig. 3). For O-alkylated dimers, the conformations
obtained depended on the composition of the side-chains. For
the dimer 1 bearing complementary terminal carboxylate and
ammonium groups in the side-chains, the syn-conformation was
preferred (100 of 100 low energy conformers, Fig. 3a), stabilised
by side-chain to side-chain H-bonding. For the dimer 2 bearing
two terminal carboxylates on the side-chains, the anti-confor-
mation was predominant (100 of 100 low energy conformers
Fig. 3b); and finally, for the dimer 3 bearing two alkyl sBu groups
as side-chains, a mixture of syn- and anti-conformation was
observed (86 : 14 syn : anti ratio for the 100 lowest energy confor-
mers, Fig. 3c). The potential for pH and therefore protonation
state to aﬀect conformational preference was further explored by
modelling the dimers in diﬀerent states (see ESI, Fig. ESI16–18†).
These indicate that dimer 1 prefer the syn- conformation in all
protonation states other than where the carboxylic acid is depro-
tonated resulting in repulsion of the amine. Dimer 2 on the
other hand prefers an anti-conformation when both carboxylic
acids are deprotonated, but the syn- conformation is enabled by
carboxylic acid dimerization.
Fig. 4 NMR studies demonstrating propensity for side-chains to control syn-/anti-conformational preference in helix mimetics: (a) 1H–1H NOESY
spectrum of compound 1 (i) 2–4.5 ppm and (ii) 7–9 ppm (500 MHz, DMSO-d6, 40 mM) together with expansion highlighting key diagnostic NOE (b)
1H–1H NOESY spectrum of compound 2 (7–9 ppm, 500 MHz, DMSO-d6, 40 mM), together with expansion highlighting key diagnostic NOEs; (c)
1H–1H NOESY spectrum of compound 3 (7–9 ppm, 500 MHz, DMSO-d6, 40 mM), together with expansion highlighting key diagnostic NOEs.
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Using 1H–1H NOESY NMR (Fig. 4), we could establish that
the capability for dimer 1 to form a hydrogen-bond between
the two side-chains promoted the syn-conformation (in con-
trast to mimetics bearing only acidic or aliphatic side-chains).
A NOE between 1-alkoxy or 2-alkoxy side-chain resonances was
not observed, however this was not surprising to us as our
models indicated that the distance between these protons (e.g.
5.2 Å between 1-Hγ and 2-Hγ) would likely result in low or no
correlations. A correlation between 2-NH and 1-H2 however
was indicative of the syn-conformer being populated whilst the
absence of a correlation between 2-NH and 1-H6 imply the
absence of the anti-conformer. Furthermore, the data match
those observed for the covalently constrained foldamer 4 (see
Fig. 2b). The syn-conformation more accurately mimics the i
and i + 4 residues in an α-helix and replicates the side-chain to
side-chain stabilization of helices observed in nature
(Fig. 1c).31,32 In contrast correlations from 2-NH to 1-H2 and
1-H6 were evident for both compounds 2 and 3 indicating the
presence of both syn- and anti-conformers. In the case of 2,
comparison to the protonation state dependent modelling
data implies a mixture of protonation states in the experi-
mental sample. Thus the modelling and experimental data
indicate hydrogen-bonding between adjacent side chains can
control conformation in aromatic oligoamides, and imply that
pH could be used to regulate this. Such pH switchable folda-
mers will be explored in future work.
Conclusions
In summary we report side-chain mediated conformational
control in model aromatic oligoamide helix mimetics. Such
control might be exploited in the context of bifacial helix
mimetics48 to more eﬀectively pre-organise side-chains on the
opposing face for recognition of proteins and consequent inhi-
bition of α-helix mediated PPIs.38 Similarly, the ability to more
accurately mimic the conformational control exhibited by
peptides might be exploited in future eﬀorts to construct
tertiary49,50 and quaternary structures from this class of
foldamer.
Experimental section
General considerations
Unless stated otherwise, solvents and reagents were used as
received from major suppliers without prior purification.
Anhydrous acetonitrile, chloroform, dichloromethane were
obtained from the in-house solvent purification system from
Innovative Technology Inc. PureSolv®. Anhydrous dimethyl-
sulfoxide was obtained from major chemical suppliers
equipped with a SureSeal or equivalent. Non-anhydrous sol-
vents were of HPLC quality and provided by Fisher or Sigma-
Aldrich. Water used for formation of aqueous solutions and
quenching was deionised. Thin Layer Chromatography (TLC)
was performed on Merck Kieselgel 60 F254 0.25 mm precoated
aluminium plates. Product spots were visualised under UV
light (λmax = 254 nm) and/or staining with anisaldehyde.
Purifications were performed with either silica gel 60
(0.043–0.063 mm VWR) using head bellows or by flash chrom-
atography using an Isolera Four Biotage®. HPLC experiments
were run on an Agilent 1290 Infinity Analytical Preparative
system. 1H NMR spectra were recorded on Bruker DPX 300
(300 MHz) or Avance 500 (500 MHz) spectrometers and refer-
enced to residual non-deuterated solvent peaks. 13C NMR were
recorded on a Bruker Advance 500 (125 MHz) and referenced
to the solvent peak. Chemical shifts (δ) are expressed in part
per million (ppm) and coupling constants are expressed in
hertz (Hz). Spectral assignments were facilitated by COSY,
HMQC and HMBC experiments when appropriate. HPLC
LC-MS were recorded on a Bruker HCT ultra under the con-
ditions of electrospray ionisation (ESI). HPLC separation was
performed on an Agilent 1200 series instrument equipped
with a Phenomenex C18 column (50 × 2 mm) using aceto-
nitrile/water/1% formic acid as the eluent for positive ion
spectra. HRMS were performed using a Bruker Maxis impact
mass spectrometer, using ESI.
Dimer synthesis
Glycine loaded Wang resin (0.79 mmol g−1, 100–200 mesh;
carrier: polystyrene, crosslinked with 1% DVB; 127 mg,
0.1 mmol) was swelled in anhydrous N-methyl-2-pyrrolidone
(5 mL) 15 minutes prior to reaction. The appropriate mono-
mers were dissolved in anhydrous N-methyl-2-pyrrolidone and
pre-activated for coupling with Ghosez’s reagent (20% in
chloroform) for 1 hour at 50 °C. The reactions were carried out
on a CEM Liberty® automated microwave assisted peptide
synthesizer, under microwave heating, following the con-
ditions detailed in Table 1. Before each coupling, standard
washing and deprotection (25% piperidine solution in
N-methyl-2-pyrrolidone) cycles were carried out on the synthe-
sizer. The samples on resin were washed with dichloro-
methane and diethyl ether. When required, cleavage oﬀ the
resin was performed manually, using a 50% solution of TFA in
dichloromethane (2 mL). TFA was removed by bubbling the
solution with nitrogen and the solvent was evaporated under
vacuum.
To simplify NMR assignment of the trimers, the following
nomenclature is used. The monomers constituting the dimers/
Table 1 Conditions for SPPS for O-alkylated scaﬀold
Monomer (mmol) Ghosez (mmol) NMP (mL) Method Coupling time (min) Temperature (°C)
0.2 0.2 4 Single 30 50
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trimers are considered separately, numbered 1 to 2 or 3 start-
ing from the N-terminus, and the glycine is numbered 3 or 4.
All the monomers are numbered following the same standard
system: the carbon bearing the carboxylic acid is C1 and the
one bearing the amine is C4. The carbon attached to the nitro-
gen is Cα, and the numbering of the aliphatic part of the
chain continues with Cβ, etc. Numbering of protons corres-
ponds to numbering of the carbons (Fig. 5). For clarity, the
monomer number is added as a prefix to the proton number.
4-(2-Amino-5-((2-(3-aminopropoxy)-4-((carboxymethyl)
carbamoyl)phenyl)carbamoyl)-phenoxy)butanoic acid 1
Using the general SPPS procedure with 4-((((9H-fluoren-9-yl)
methoxy)carbonyl)amino)-3-(3-((tert-butoxycarbonyl)amino)pro-
poxy)benzoic acid (107 mg, 0.2 mmol); 4-((((9H-fluoren-9-yl)
methoxy)carbonyl)amino)-3-(4-(tert-butoxy)-4-oxobutoxy)benzoic
acid (104 mg, 0.2 mmol). The residue was purified using semi-
preparative HPLC (eluent: acetonitrile/water/formic acid:
0.5/9.5/0.1 to 9.5/0.5/0.1) and the product was collected as a
pale cream powder (9.3 mg, 19%): δH (500 MHz, DMSO-d6)
9.01 (s, 1H, 2-NH), 8.48 (s, 1H, 3-NH), 8.11 (d, 1H, J = 8.3 Hz,
2-H5), 7.55 (s, 1H, 2-H2), 7.50 (d, 1H, J = 8.3 Hz, 2-H6), 7.38 (s,
1H, 1–H6), 7.36 (s, 1H, 1-H2), 6.71 (d, 1H, J = 8.1 Hz, 1-H5),
5.43 (s broad, 2H, NH2), 4.18 (t, 2H, J = 5.5 Hz, 2-Hα), 4.05 (t,
2H, J = 6.5 Hz, 1-Hα), 3.79 (d, 2H, J = 4.9 Hz, 3-Hα), 2.99 (t, 2H,
J = 6.6 Hz, 2-Hγ), 2.29 (t, 2H, J = 6.6 Hz, 1-Hγ), 2.08–2.15 (m,
2H, 2-Hβ), 1.96–2.01 (m, 2H, 1-Hβ); δC (125 MHz, DMSO-d6)
175.7, 171.8, 166.2, 165.2, 149.1, 145.0, 142.5, 131.1, 130.1,
130.0, 122.4, 121.6, 121.3, 120.2, 112.9, 111.2, 110.3, 68.0,
66.0, 42.2, 36.7, 27.7, 25.4. HRMS: Calcd [M + H]+
(C23H29N4O8) m/z = 489.1980, found [M + H]
+ m/z = 489.1978.
4-(2-(4-Amino-3-(3-carboxypropoxy)benzamido)-5-
((carboxymethyl)carbamoyl)phenoxy)-butanoic acid 2
Using the general SPPS procedure with 4-((((9H-fluoren-9-yl)
methoxy)carbonyl)amino)-3-(4-(tert-butoxy)-4-oxobutoxy)benzoic
acid (104 mg, 0.2 mmol) for each cycle of coupling. The
residue was purified using semi-preparative HPLC (eluent:
acetonitrile/water/formic acid: 0.5/9.5/0.1 to 9.5/0.5/0.1) and
the product was collected as a pale cream powder (4.6 mg,
9%); δH (500 MHz, DMSO-d6) 8.98 (s, 1H, 2-NH), 8.77 (t, 1H, J =
5.9 Hz, 3-NH), 8.14 (d, 1H, J = 8.4 Hz, 2-H5), 7.53 (d, 1H, J =
1.7 Hz, 2-H2), 7.50 (dd, 1H, J = 8.4, 1.7 Hz, 2-H6), 7.36 (dd, 1H,
J = 8.1, 1.9 Hz, 1-H6), 7.34 (d, 1H, J = 1.9 Hz, 1-H2), 6.68 (d, 1H,
J = 8.1 Hz, 1-H5), 4.14 (t, 2H, J = 6.2 Hz, 2-Hα), 4.04 (t, 2H, J =
6.2 Hz, 1-Hα), 3.92 (d, 2H, J = 5.8 Hz, 3-Hα), 2.44–2.47 (m, 4H,
1-Hγ and 2-Hγ), 2.05 (quint., 2H, J = 6.7 Hz, 2-Hβ), 1.99 (quint,
2H, J = 6.7 Hz, 1-Hβ); δC (125 MHz, DMSO-d6) 174.9, 174.7,
171.9, 166.4, 165.1, 148.9, 145.0, 142.6, 131.3, 129.6, 122.0,
121.3, 121.1, 120.4, 112.7, 111.0, 110.7, 68.2, 67.5, 41.6, 30.9,
30.8, 24.8, 24.7; HRMS: Calcd [M + H]+ (C24H28N3O10) m/z =
518.1769, found [M + H]+ m/z = 518.1775.
(4-(4-Amino-3-(sec-butoxy)benzamido)-3-(sec-butoxy)benzoyl)
glycine 3
Using the general SPPS procedure with 44-((((9H-fluoren-9-yl)
methoxy)carbonyl)amino)-3-(sec-butoxy)benzoic acid (86 mg,
0.2 mmol) for each cycle of coupling. The residue was purified
using semi-preparative HPLC (eluent: acetonitrile/water/formic
acid: 0.5/9.5/0.1 to 9.5/0.5/0.1) and the product isolated as a
dark yellow solid (10 mg, 22%); δH (500 MHz, DMSO-d6) 8.89
(s, 1H, 2-NH), 8.74 (t, 1H, 3-NH) 8.24 (d, 1H, J = 8.4 Hz, 2-H5),
7.56 (d, 1H, J = 1.7 Hz, 2-H2), 7.52 (dd, 1H, J = 8.4 Hz, 1.7 Hz,
2-H6), 7.34–7.31 (m, 1H, 1-H2), 7.30 (d, 1H, J = 1.9 Hz, 1-H6),
6.72 (d, 1H, J = 8.1 Hz, 1-H5), 5.41 (s, 2H, 1-NH2), 4.56 (sxt.,
1H, J = 5.9 Hz, 2-Hα), 4.40 (sxt., 1H, J = 5.9 Hz, 1-Hα), 3.92 (d,
2H, J = 5.9 Hz, 3-Hα), 1.79–1.61 (m, 4H, 1-Hβ, 2-Hβ), 1.32 (dd,
3H, J = 6.1 Hz, 1.3 Hz, 2-CHα(CH3)), 1.28 (dd, 3H, J = 6.1 Hz,
2.3 Hz, 1-CHα(CH3)), 0.99–0.94 (m, 6H, 1-Hγ, 2-Hγ);
δC (125 MHz, DMSO-d6) 171.4, 165.8, 164.4, 147.0, 143.5,
143.2, 131.7, 128.9, 121.1, 120.9, 119.9, 112.8, 112.2, 76.0, 75.3,
41.3, 40.4, 28.6, 28.5, 19.1, 19.0 18.9, 9.6, 9.4; HRMS: Calcd
[M + H]+ (C24H32N3O6) m/z = 458.2286, found [M + H]
+ m/z =
458.2299.
Trimer 4
Trimer 4 was prepared directly from cross-linked dimer using
procedure (b) followed by coupling with using dichlorotriphe-
nyl phosphorene in chloroform as previously described. Yield:
26%; mp: 237 °C; 1H (CDCl3, 500 MHz) δ: 8.66–8.63 (m, 3H,
1-NH, 2-H5, 3-H5), 8.49 (s, 1H, 2-NH), 7.95–7.93 (d, J = 8.3 Hz,
1H, 1-H5), 7.78 (s, 1H, 1-H2), 7.75–7.72 (m, 2H, 2-H6, 3-H6),
7.56 (s, 1H, 3-H2), 7.50–7.48 (m, 2H, Ph-H1), 7.43–7.40 (m, 3H,
1-H6, Ph-H2), 7.37–7.34 (m, 1H, Ph-H3), 7.17 (s, 1H, 2-H2),
5.34 (s, 2H, OCH2Ph), 4.33–4.30 (m, 2H, OCH2), 4.17–4.15 (m,
2H, OCH2), 3.91 (s, 3H, OCH3), 1.89–1.83 (m, 4H, CH2),
1.61–1.50 (m, 8H, CH2);
13C (CDCl3, 125 MHz) δ: 166.8, 165.3,
163.1, 152.2, 146.9, 146.6, 142.1, 139.8, 135.0, 132.0, 131.2,
131.0, 128.8, 128.5, 127.2, 125.9, 125.2, 123.3, 122.7, 120.4,
118.7, 117.9, 115.0, 111.1, 107.4, 71.5, 69.3, 68.6, 52.1, 29.3,
26.8, 26.6, 26.4, 24.7, 22.1; IR (neat) ν (cm−1): 3424, 2934, 2864,
1722, 1689, 1667, 1594, 1515, 1345, 1262, 1204, 1124, 1108,
1006; HRMS: Calcd [M − H]− (C37H36N3O9) m/z = 666.2452.
Found [M − H]− m/z = 666.2485. Elemental analysis calculated
for C37H37N3O9: C, 66.56; H, 5.59; N, 6.29; Found: C, 65.85; N,
5.50; N, 6.00.
Fig. 5 Example of numbering for an O-alkylated dimer 1.
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Procedure for modelling
Monte Carlo Multiple Minima (MCMM) molecular mechanics
conformational search was carried out using MacroModel
(Schrödinger) and the Merck Molecular Force Field (MMFF),
with a cut-oﬀ of 1 Å in implicit water. The calculation used a
maximum of 10 000 steps and maximum of 100 steps per
rotational bond, 100 structures were saved within an energy
window of 10 kJ mol−1. Angle and torsional constraints with a
force field of 1000 were applied to all amine and amide func-
tional groups to fix an sp2 conformation and charges were set
to account for the pKa of the relevant groups and anticipated
protonation state.
Conformational analyses by 1H NMR
NMR experiments performed to determine the conformation
of the dimers 1–3 and trimer 4 were acquired on a Bruker
Avance 500, at 500 MHz and 26 °C (parameters in Table 2).
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